
XWEL Valuation
XWELL Inc
- Overview
- Forecast
- Valuation
- Earnings
XWEL Relative Valuation
XWEL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, XWEL is overvalued; if below, it's undervalued.
Historical Valuation
XWELL Inc (XWEL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.17 is considered Undervalued compared with the five-year average of -10.24. The fair price of XWELL Inc (XWEL) is between 1.42 to 1.94 according to relative valuation methord. Compared to the current price of 1.13 USD , XWELL Inc is Undervalued By 20.55%.
Relative Value
Fair Zone
1.42-1.94
Current Price:1.13
20.55%
Undervalued
-0.43
PE
1Y
3Y
5Y
Trailing
Forward
-1.98
EV/EBITDA
XWELL Inc. (XWEL) has a current EV/EBITDA of -1.98. The 5-year average EV/EBITDA is -2.28. The thresholds are as follows: Strongly Undervalued below -12.43, Undervalued between -12.43 and -7.36, Fairly Valued between 2.79 and -7.36, Overvalued between 2.79 and 7.86, and Strongly Overvalued above 7.86. The current Forward EV/EBITDA of -1.98 falls within the Historic Trend Line -Fairly Valued range.
-1.41
EV/EBIT
XWELL Inc. (XWEL) has a current EV/EBIT of -1.41. The 5-year average EV/EBIT is -0.39. The thresholds are as follows: Strongly Undervalued below -10.05, Undervalued between -10.05 and -5.22, Fairly Valued between 4.45 and -5.22, Overvalued between 4.45 and 9.28, and Strongly Overvalued above 9.28. The current Forward EV/EBIT of -1.41 falls within the Historic Trend Line -Fairly Valued range.
0.17
PS
XWELL Inc. (XWEL) has a current PS of 0.17. The 5-year average PS is 1.63. The thresholds are as follows: Strongly Undervalued below -3.24, Undervalued between -3.24 and -0.80, Fairly Valued between 4.07 and -0.80, Overvalued between 4.07 and 6.50, and Strongly Overvalued above 6.50. The current Forward PS of 0.17 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
XWELL Inc. (XWEL) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
XWELL Inc. (XWEL) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
XWELL Inc (XWEL) has a current Price-to-Book (P/B) ratio of -1.15. Compared to its 3-year average P/B ratio of 0.49 , the current P/B ratio is approximately -333.67% higher. Relative to its 5-year average P/B ratio of 1.02, the current P/B ratio is about -212.86% higher. XWELL Inc (XWEL) has a Forward Free Cash Flow (FCF) yield of approximately -258.07%. Compared to its 3-year average FCF yield of -176.93%, the current FCF yield is approximately 45.85% lower. Relative to its 5-year average FCF yield of -108.25% , the current FCF yield is about 138.41% lower.
-1.15
P/B
Median3y
0.49
Median5y
1.02
-258.07
FCF Yield
Median3y
-176.93
Median5y
-108.25
Competitors Valuation Multiple
The average P/S ratio for XWEL's competitors is 0.46, providing a benchmark for relative valuation. XWELL Inc Corp (XWEL) exhibits a P/S ratio of 0.17, which is -63.21% above the industry average. Given its robust revenue growth of -17.16%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of XWEL decreased by 40.53% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -19.30 to -26.69.
The secondary factor is the Revenue Growth, contributed -17.16%to the performance.
Overall, the performance of XWEL in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

IMG
CIMG Inc
0.264
USD
-7.38%

QNTM
Quantum Biopharma Ltd
16.850
USD
-2.32%

PLRZ
Polyrizon Ltd
1.090
USD
+4.81%

CMND
Clearmind Medicine Inc
1.055
USD
+3.43%

GRI
GRI Bio Inc
1.390
USD
0.00%

XHG
XChange TEC.INC
1.210
USD
0.00%

BLBX
Blackboxstocks Inc
6.300
USD
-1.10%

ONFO
Onfolio Holdings Inc
1.040
USD
+2.97%

XBIO
Xenetic Biosciences Inc
2.850
USD
0.00%

EVOK
Evoke Pharma Inc
5.450
USD
+3.02%
FAQ

Is XWELL Inc (XWEL) currently overvalued or undervalued?
XWELL Inc (XWEL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.17 is considered Undervalued compared with the five-year average of -10.24. The fair price of XWELL Inc (XWEL) is between 1.42 to 1.94 according to relative valuation methord. Compared to the current price of 1.13 USD , XWELL Inc is Undervalued By 20.55% .

What is XWELL Inc (XWEL) fair value?

How does XWEL's valuation metrics compare to the industry average?

What is the current P/B ratio for XWELL Inc (XWEL) as of Aug 29 2025?

What is the current FCF Yield for XWELL Inc (XWEL) as of Aug 29 2025?

What is the current Forward P/E ratio for XWELL Inc (XWEL) as of Aug 29 2025?
